-1 week | 0 week | 3 weeks | 6 weeks | 3 weeks after treatment | 6 weeks after treatment | |
---|---|---|---|---|---|---|
Baseline | Treatment phase | Follow-up phase | ||||
Patients | X | |||||
Informed consent | x | |||||
Medical history | x | |||||
Physical examination | x | |||||
Randomization | ||||||
Intervention | ||||||
Affected meridian acupuncture group (n = 107) | 18 sessions of acupuncture at acupoints | |||||
Non-affected meridian acupuncture group (n = 107) | ||||||
Comparisons | ||||||
Incasive sham acupuncture group (n = 107) | 18 sessions of acupuncture at non-acupoints | |||||
Waiting-list group (n = 107) | 18 sessions of treatment at the end of the trial | |||||
Outcomes | ||||||
24-h blood pressure | x | x | x | x | ||
Expectation of acupuncture | x | |||||
SF- 36 | x | x | ||||
Response to treatment | x | |||||
Participants safety | ||||||
Laboratory test | x | |||||
Adverse events | x | x | x | x | x |